Please ensure Javascript is enabled for purposes of website accessibility
Accueil > Products > Protéines Recombinantes > Autres Protéines

Human HGFR/c-MET Recombinant Protein (C-Fc) (HY196011)

Human HGFR/c-MET Recombinant Protein (C-Fc)
Human HGFR/c-MET Recombinant Protein (C-Fc)
Human HGFR/c-MET Recombinant Protein (C-Fc)
Human HGFR/c-MET Recombinant Protein (C-Fc)
Human HGFR/c-MET Recombinant Protein (C-Fc)
Human HGFR/c-MET Recombinant Protein (C-Fc)
Human HGFR/c-MET Recombinant Protein (C-Fc)
Human HGFR/c-MET Recombinant Protein (C-Fc)
Prix(USD) :
Spécification :
  • 50ug
  • 100ug
  • 1mg
Nombre :
Contactez-nous
  • Aperçu

  • Images

  • Reférences

  • Fiche technique

  • SDS

Aperçu
Numéro de catalogueHY196011
Description
Recombinant Human MET/c-Met/HGFR Protein, C-Fc (HY196011) expressed in Mammalian Cells, spanning Met1-Thr932.
Highlights
  • ●Fc Fusion — Enhanced stability with Protein A/G purification compatibility.
  • ●Mammalian Expression — Proper folding and native glycosylation.
  • ●High Purity — >90% purity verified by SDS-PAGE.
Système d'expressionMammalian cells
Numéro d'accèsP08581
Longueur de protéineMet1-Thr932
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
EspècesHomo sapiens (Human)
Nature Recombinant
Applications testées WB
Niveau d'endotoxines Please contact with the lab for this information.
Pureté >95% as determined by SDS-PAGE.
Masse moléculaire prédite 130.53 kDa
Forme Lyophilized
Tampon de stockage Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.

Reconstitution Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Expédition In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stabilité et stockage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Noms alternatifsTyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET, RCCP2
Contexte

Hepatocyte growth factor receptor (MET/HGFR) is a ~155 kDa protein. Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. MET is the therapeutic target of amivantamab (Rybrevant).

Note For research use only.
Images
  • Human HGFR/c-MET Recombinant Protein (C-Fc)

    SDS-PAGE

    SDS-PAGE for Recombinant Human MET/c-Met/HGFR Protein, C-Fc

  • Human HGFR/c-MET Recombinant Protein (C-Fc)

    Bioactivity

    Detects Emibetuzumab in indirect ELISAs.

  • Human HGFR/c-MET Recombinant Protein (C-Fc)

    Bioactivity

    Detects Telisotuzumab in indirect ELISAs.

  • Human HGFR/c-MET Recombinant Protein (C-Fc)

    Western blot

    Detected by Anti-MET/c-Met/HGFR monoclonal antibody (Catalog No: HY196016)

Reférences
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommandation

Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.

Courrier : [email protected]

Liste des distributeurs